189 related articles for article (PubMed ID: 36397645)
21. Reducing PTV margins for prostate SBRT with motion compensation and gating techniques.
Goddard L; Jeong K; Tang J; Garg M; Tomé WA
J Appl Clin Med Phys; 2023 Apr; 24(4):e13861. PubMed ID: 36478148
[TBL] [Abstract][Full Text] [Related]
22. A motion phantom study on helical tomotherapy: the dosimetric impacts of delivery technique and motion.
Kanagaki B; Read PW; Molloy JA; Larner JM; Sheng K
Phys Med Biol; 2007 Jan; 52(1):243-55. PubMed ID: 17183139
[TBL] [Abstract][Full Text] [Related]
23. A novel four-dimensional radiotherapy planning strategy from a tumor-tracking beam's eye view.
Li G; Cohen P; Xie H; Low D; Li D; Rimner A
Phys Med Biol; 2012 Nov; 57(22):7579-98. PubMed ID: 23103415
[TBL] [Abstract][Full Text] [Related]
24. Reduction of dosimetric impact of intrafractional prostate motion during helical tomotherapy.
Prokic V; Geinitz H; Kneschaurek P
Strahlenther Onkol; 2012 May; 188(5):404-9. PubMed ID: 22349631
[TBL] [Abstract][Full Text] [Related]
25. Three-dimensional analysis of the respiratory interplay effect in helical tomotherapy: Baseline variations cause the greater part of dose inhomogeneities seen.
Tudor GS; Harden SV; Thomas SJ
Med Phys; 2014 Mar; 41(3):031704. PubMed ID: 24593708
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric evaluation of MRI-guided multi-leaf collimator tracking and trailing for lung stereotactic body radiation therapy.
Uijtewaal P; Borman PTS; Woodhead PL; Hackett SL; Raaymakers BW; Fast MF
Med Phys; 2021 Apr; 48(4):1520-1532. PubMed ID: 33583042
[TBL] [Abstract][Full Text] [Related]
27. Single-fraction prostate stereotactic body radiotherapy: Dose reconstruction with electromagnetic intrafraction motion tracking.
Jaccard M; Ehrbar S; Miralbell R; Hagen T; Koutsouvelis N; Poulsen P; Rouzaud M; Tanadini-Lang S; Tsoutsou P; Guckenberger M; Zilli T
Radiother Oncol; 2021 Mar; 156():145-152. PubMed ID: 33310011
[TBL] [Abstract][Full Text] [Related]
28. [Serial tomotherapy vs. MLC-IMRT (multileaf collimator intensity modulated radiotherapy) for simultaneous boost treatment large intracerebral lesions].
Wolff D; Abo-Madyan Y; Dobler B; Lohr F; Mai S; Polednik M; Wenz F
Z Med Phys; 2009; 19(1):58-66. PubMed ID: 19459586
[TBL] [Abstract][Full Text] [Related]
29. A dosimetric analysis comparing treatment of low-risk prostate cancer with TomoTherapy versus static field intensity modulated radiation therapy.
Shah AP; Chen SS; Strauss JB; Kirk MC; Coleman JL; Coon AB; Miller C; Dickler A
Am J Clin Oncol; 2009 Oct; 32(5):460-6. PubMed ID: 19564784
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric feasibility of neurovascular bundle-sparing stereotactic body radiotherapy with periprostatic hydrogel spacer for localized prostate cancer to preserve erectile function.
Hwang ME; Mayeda M; Shaish H; Elliston CD; Spina CS; Wenske S; Deutsch I
Br J Radiol; 2021 Mar; 94(1119):20200433. PubMed ID: 33586999
[TBL] [Abstract][Full Text] [Related]
31. The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial.
Nikitas J; Smith LM; Gao Y; Ma TM; Sachdeva A; Yoon SM; Jiang T; Low DA; Ballas LK; Steinberg ML; Cao M; Kishan AU
Radiother Oncol; 2023 Jun; 183():109631. PubMed ID: 36934894
[TBL] [Abstract][Full Text] [Related]
32. Experimental investigation of dynamic real-time rotation-including dose reconstruction during prostate tracking radiotherapy.
Muurholm CG; Ravkilde T; De Roover R; Skouboe S; Hansen R; Crijns W; Depuydt T; Poulsen PR
Med Phys; 2022 Jun; 49(6):3574-3584. PubMed ID: 35395104
[TBL] [Abstract][Full Text] [Related]
33. MLC tracking for lung SABR reduces planning target volumes and dose to organs at risk.
Caillet V; Keall PJ; Colvill E; Hardcastle N; O'Brien R; Szymura K; Booth JT
Radiother Oncol; 2017 Jul; 124(1):18-24. PubMed ID: 28655454
[TBL] [Abstract][Full Text] [Related]
34. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
35. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
[TBL] [Abstract][Full Text] [Related]
36. Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?
Dubouloz A; Rouzaud M; Tsvang L; Verbakel W; Björkqvist M; Linthout N; Lencart J; Pérez-Moreno JM; Ozen Z; Escude L; Zilli T; Miralbell R
Radiat Oncol; 2018 Jun; 13(1):114. PubMed ID: 29921291
[TBL] [Abstract][Full Text] [Related]
37. Robust plan optimization for electromagnetic transponder guided hypo-fractionated prostate treatment using volumetric modulated arc therapy.
Zhang P; Hunt M; Happersett L; Yang J; Zelefsky M; Mageras G
Phys Med Biol; 2013 Nov; 58(21):7803-13. PubMed ID: 24145674
[TBL] [Abstract][Full Text] [Related]
38. Transperineal ultrasound is a good alternative for intra-fraction motion monitoring for prostate stereotactic body radiotherapy.
Guo B; Stephans K; Godley A; Kolar M; Magnelli A; Tendulkar R; Mian O; Majkszak D; Xia P
J Appl Clin Med Phys; 2023 Oct; 24(10):e14021. PubMed ID: 37144947
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
[TBL] [Abstract][Full Text] [Related]
40. Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer.
Schaule J; Chamberlain M; Wilke L; Baumgartl M; Krayenbühl J; Zamburlini M; Mayinger M; Andratschke N; Tanadini-Lang S; Guckenberger M
Radiat Oncol; 2021 Sep; 16(1):189. PubMed ID: 34565439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
